Capsugel

Introduction Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic...

Understanding patient attitudes and preferences has become an essential part of modern therapeutic decision making. The effectiveness of therapies doesn’t...

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

The exclusivity period and subsequent loss of exclusivity (LOE) are critical points in the lifecycle of any drug, particularly for...

New formulation strategies are beginning to yield clinically and commercially viable oral biological therapies, according to a Lonza whitepaper published...

Enteric capsules are widely used to protect acid‑sensitive compounds and to delay drug release until intestinal entry. However, evidence supporting...

Abstract The dynamic and transitory nature of the distal small intestine makes targeted drug delivery to this region particularly challenging....

Abstract Background/Objectives: Cholera remains an important global health problem. Inactivated oral cholera vaccines (OCVs) are essential in the WHO/GTFCC (World...

Capsugel®/ Lonza published a new podcast episode: For years, oral delivery of biologics has been viewed as impractical. But what...

Capsugel® Enprotect® capsule enables enteric delivery without the need for a post-filling coating step. This helps protect your sensitive active...